Growth Metrics

Omeros (OMER) Profit After Tax (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -40.72%
Dec 31, 2025 379.62%
Sep 30, 2025 -21.61%
Jun 30, 2025 24.02%
Mar 31, 2025 -211.92%
Dec 31, 2024 71.10%
Sep 30, 2024 33.78%
Jun 30, 2024 -50.71%
Mar 31, 2024 5.35%
Dec 31, 2023 -4.07%
Sep 30, 2023 -1.22%
Jun 30, 2023 -10.66%
Mar 31, 2023 26.81%
Dec 31, 2022 15.96%
Sep 30, 2022 -77.61%
Jun 30, 2022 6.55%
Mar 31, 2022 -111.76%
Dec 31, 2021 733.77%
Sep 30, 2021 -54.86%
Jun 30, 2021 18.52%
Mar 31, 2021 5.86%
Dec 31, 2020 3.09%
Sep 30, 2020 -15.53%
Jun 30, 2020 -14.68%
Mar 31, 2020 0.66%
Dec 31, 2019 -77.52%
Sep 30, 2019 -13.91%
Jun 30, 2019 40.63%
Mar 31, 2019 -3.45%
Dec 31, 2018 40.38%
Sep 30, 2018 -17.14%
Jun 30, 2018 -12.12%
Mar 31, 2018 -81.58%
Dec 31, 2017 -121.21%
Sep 30, 2017 47.89%
Jun 30, 2017 4.84%
Mar 31, 2017 23.14%
Dec 31, 2016 -40.61%
Sep 30, 2016 -10.70%
Jun 30, 2016 38.59%
Mar 31, 2016 -3.60%
Dec 31, 2015 0.48%
Sep 30, 2015 -19.43%
Jun 30, 2015 10.65%
Mar 31, 2015 9.87%
Dec 31, 2014 -13.02%
Sep 30, 2014 -1.87%
Jun 30, 2014 -8.11%
Mar 31, 2014 -802.01%
Dec 31, 2013 86.70%
Sep 30, 2013 -2.05%
Jun 30, 2013 -29.58%
Mar 31, 2013 -35.62%
Dec 31, 2012 41.74%
Sep 30, 2012 -55.47%
Jun 30, 2012 4.00%
Mar 31, 2012 12.80%
Dec 31, 2011 -56.65%
Sep 30, 2011 -23.08%
Jun 30, 2011 19.12%
Mar 31, 2011 9.53%
Dec 31, 2010 4.29%
Sep 30, 2010 3.19%